• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他莫昔芬治疗中增厚子宫内膜的评估。

Assessment of thickened endometrium in tamoxifen therapy.

作者信息

Korkmazer Engin, Solak Neşe, Tokgöz Vehbi Yavuz

机构信息

Giresun University Faculty of Medicine, Department of Gynecology and Obstetrics, Giresun, Turkey.

Giresun Maternity and Chilt Health Hospital, Clinic of Gynecology and Obstetrics, Giresun, Turkey.

出版信息

Turk J Obstet Gynecol. 2014 Dec;11(4):215-218. doi: 10.4274/tjod.82621. Epub 2014 Dec 15.

DOI:10.4274/tjod.82621
PMID:28913023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5558364/
Abstract

OBJECTIVE

Aim of this study was to evaluate role of hysteroscopy in thickened endometrium (>5 mm) associated with tamoxifen therapy.

MATERIALS AND METHODS

We performed dilatation and curettage (D&C) and hysteroscopic biopsy to patients for evaluation of thickened endometrium in tamoxifen therapy. One hundred and nine asymptomatic patients with estrogen receptor positive breast cancer treated with tamoxifen 20 mg daily. We performed hysteroscopic biopsy or D&C to patients who have thickened endometrium at transvaginal sonography. We correlate pathology report results of D&C and hysteroscopic biopsy.

RESULTS

Fifty-nine of 103 patients have thickened endometrium.Thirty-five of 59 patients diagnosed with D&C (19 inactive endometrium, 15 endometrial polyp, 1 endometrial hyperplasia). D&C couldn't get material 24 of these patients. Hysteroscopic biopsy diagnosed endometrial polyp 11 (45.8%) of these patients.

CONCLUSION

We can state that D&C does not seem accurate enough for detection of intrauterin pathologies in thickened endometrium associated with tamoxifen therapy. We therefore believe it is reasonable to perform hysteroscopic biopsy in asymptomatic tamoxifen treated patients who have thickened endometrium.

摘要

目的

本研究的目的是评估宫腔镜检查在他莫昔芬治疗相关的子宫内膜增厚(>5mm)中的作用。

材料与方法

我们对接受他莫昔芬治疗的子宫内膜增厚患者进行了刮宫术(D&C)和宫腔镜活检。109例无症状的雌激素受体阳性乳腺癌患者,每日服用20mg他莫昔芬。对经阴道超声检查显示子宫内膜增厚的患者进行了宫腔镜活检或刮宫术。我们将刮宫术和宫腔镜活检的病理报告结果进行了关联。

结果

103例患者中有59例子宫内膜增厚。59例患者中35例经刮宫术诊断(19例为静止期子宫内膜,15例为子宫内膜息肉,1例为子宫内膜增生)。其中24例患者刮宫术未能获取组织。宫腔镜活检诊断这些患者中有11例(45.8%)为子宫内膜息肉。

结论

我们可以说,刮宫术对于检测他莫昔芬治疗相关的子宫内膜增厚中的子宫内病变似乎不够准确。因此,我们认为对于无症状的接受他莫昔芬治疗且子宫内膜增厚的患者进行宫腔镜活检是合理的。

相似文献

1
Assessment of thickened endometrium in tamoxifen therapy.他莫昔芬治疗中增厚子宫内膜的评估。
Turk J Obstet Gynecol. 2014 Dec;11(4):215-218. doi: 10.4274/tjod.82621. Epub 2014 Dec 15.
2
Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen.盐水宫腔超声造影用于监测服用他莫昔芬的无症状绝经后乳腺癌患者。
Int J Gynaecol Obstet. 1999 Nov;67(2):81-6. doi: 10.1016/s0020-7292(99)00124-1.
3
Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen.在接受他莫昔芬治疗的乳腺癌患者中,经阴道超声测量的子宫内膜厚度估计值与宫腔镜检查及定向活检结果之间存在不一致。
Anticancer Res. 2000 Nov-Dec;20(6C):4889-91.
4
Hysteroscopic assessment of postmenopausal endometrial thickening.绝经后子宫内膜增厚的宫腔镜评估
Prz Menopauzalny. 2014 Dec;13(6):330-3. doi: 10.5114/pm.2014.47985. Epub 2014 Dec 30.
5
The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.经阴道超声和生理盐水灌注子宫声学造影在评估无症状绝经后乳腺癌患者使用他莫昔芬情况中的应用
Ultrasound Obstet Gynecol. 1998 Jan;11(1):48-53. doi: 10.1046/j.1469-0705.1998.11010048.x.
6
Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.辅助性他莫昔芬对绝经后乳腺癌女性子宫内膜的影响:一项使用经阴道超声的前瞻性长期研究
J Clin Oncol. 2000 Oct 15;18(20):3464-70. doi: 10.1200/JCO.2000.18.20.3464.
7
Sonographic, hysteroscopic, and histologic evaluation of the endometrium in postmenopausal women with breast cancer receiving tamoxifen.对接受他莫昔芬治疗的绝经后乳腺癌女性子宫内膜的超声、宫腔镜及组织学评估。
J Am Assoc Gynecol Laparosc. 2000 Feb;7(1):77-81. doi: 10.1016/s1074-3804(00)80013-4.
8
Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?对服用他莫昔芬的绝经后乳腺癌患者进行宫腔镜评估;在估计子宫内膜病变方面,子宫内膜取样方式是否存在偏差?
Breast Cancer Res Treat. 2002 Apr;72(3):245-53. doi: 10.1023/a:1014957524845.
9
Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.接受他莫昔芬治疗乳腺癌的绝经后女性子宫内膜的预处理及前瞻性评估。
Eur J Obstet Gynecol Reprod Biol. 2007 May;132(1):101-6. doi: 10.1016/j.ejogrb.2006.04.001. Epub 2006 May 5.
10
Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen.经阴道超声与诊断性宫腔镜检查在接受他莫昔芬治疗的绝经后乳腺癌患者中的对比研究。
Chin Med J (Engl). 2011 Aug;124(15):2335-9.

引用本文的文献

1
Tamoxifen-associated Endometrial Cancer after Treatment in Young Premenopausal Women with Breast Cancer: A Case Report.年轻绝经前乳腺癌患者治疗后他莫昔芬相关子宫内膜癌:一例报告
Acta Inform Med. 2023;32(1):85-87. doi: 10.5455/aim.2024.32.85-87.
2
Urolithins: The Colon Microbiota Metabolites as Endocrine Modulators: Prospects and Perspectives.尿石素:作为内分泌调节剂的结肠微生物群代谢产物:前景与展望
Front Nutr. 2022 Feb 2;8:800990. doi: 10.3389/fnut.2021.800990. eCollection 2021.

本文引用的文献

1
Endometrial pathology in breast cancer patients: Effect of different treatments on ultrasonographic, hysteroscopic and histological findings.乳腺癌患者的子宫内膜病理学:不同治疗方法对超声、宫腔镜及组织学检查结果的影响。
Oncol Lett. 2013 Apr;5(4):1305-1310. doi: 10.3892/ol.2013.1156. Epub 2013 Jan 28.
2
Management of endometrial precancers.子宫内膜癌前病变的管理。
Obstet Gynecol. 2012 Nov;120(5):1160-75. doi: 10.1097/aog.0b013e31826bb121.
3
Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.乳腺癌治疗后子宫内膜癌的生存情况与他莫昔芬治疗的关系:三个国家的汇总结果。
Breast Cancer Res. 2012 Jun 12;14(3):R91. doi: 10.1186/bcr3206.
4
Outpatient hysteroscopy: factors influencing post-procedure acceptability in patients attending a tertiary referral centre.门诊宫腔镜检查:影响三级转诊中心患者术后接受度的因素
Aust N Z J Obstet Gynaecol. 2009 Dec;49(6):650-2. doi: 10.1111/j.1479-828X.2009.01096.x.
5
Uterine pathologies in patients undergoing tamoxifen therapy for breast cancer: ultrasonographic, hysteroscopic and histological findings.接受他莫昔芬治疗的乳腺癌患者的子宫病变:超声、宫腔镜及组织学检查结果
Eur J Gynaecol Oncol. 2005;26(6):623-6.
6
[Diagnostic hysteroscopy and risk of peritoneal dissemination of tumor cells].[诊断性宫腔镜检查与肿瘤细胞腹膜播散风险]
Gynecol Obstet Fertil. 2005 Apr;33(4):247-52. doi: 10.1016/j.gyobfe.2005.03.004. Epub 2005 Apr 7.
7
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.ATAC(“阿那曲唑”、他莫昔芬,单独使用或联合使用)辅助性乳腺癌试验:关于经阴道超声检查和诊断性宫腔镜检查有效性的子宫内膜亚方案基线数据。
Hum Reprod. 2005 Jan;20(1):294-301. doi: 10.1093/humrep/deh567. Epub 2004 Oct 28.
8
The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.他莫昔芬治疗的无症状乳腺癌患者的子宫内膜:盐水灌注经阴道超声检查及多普勒血流的价值
Gynecol Oncol. 2004 May;93(2):328-35. doi: 10.1016/j.ygyno.2004.01.032.
9
Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.对接受他莫昔芬治疗的乳腺癌女性进行子宫内膜异常超声筛查的前瞻性纵向研究。
Gynecol Oncol. 2003 Oct;91(1):154-9. doi: 10.1016/s0090-8258(03)00441-4.
10
Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients.超声检查、宫腔镜检查及活检在绝经后接受他莫昔芬治疗患者子宫内膜病变诊断中的比较
Acta Obstet Gynecol Scand. 2002 Oct;81(10):975-80. doi: 10.1034/j.1600-0412.2002.811013.x.